Börse Express – ROUNDING / European Equities Conclusion: losses after disappointed hopes

Most exchanges in Europe
On Friday it yielded significantly again. Investors were disappointed.
on very little progress at the EU summit in the fight against that
Consequences of the coronavirus. Also, there is now skepticism about whether one is against
Ebola developed agent also patients with lung disease
Covid-19 could help. One reserved before the weekend
The start of the stock market in the United States also did the rest.

After the recent recovery, the EuroStoxx gave 50 um
1.52 percent to 2809.07 points after what is a weekly view
It means loss of 2.7 percent. On the Paris and London stock exchanges
things went down on Friday similarly: Cac 40
decreased 1.30 percent to 4,393.32 and FTSE 100
lost 1.28 percent to 5752.23 points.

Videoconference of EU members on aid packages and
The exit strategies from the Corona crisis could have ended better
Axitrader’s Milan Cutkovic criticized. “Came to
an agreement, but not to concrete results. “

Also, the Covid-19 hope to remdesivir des
American biotech group Gilead Sciences one the night before
He had received shock absorbers. The drug was given in China
Patients saw no noticeable improvement, they reported.
“Financial Times”. According to Stepen Innes of AxiCorp he received this message
“hit the markets” because the current
The economic situation was caused by the Corona virus.

All sectors in Europe fell. Despite the stabilization in
The oil market also made this clear at minus 2.1 percent
under pressure Course discount of 2.6 percent also contributed to this
Italian energy giant Eni to whom about a
He had reported a loss of $ 1 billion in the first quarter.

Dutch ING lost as a back light on
EuroStoxx 6.2 percent. The rating agency Standard & Poor’s had in
Eve warned that the economic recession in financial institutions
It should weigh heavily in the coming quarters. So she put that down
Credit ratings for numerous members of the industry. Downloaded for the ING
The solvency outlook is “negative”.

For sanofi the top of the index fell 2.3 percent
up The pharmaceutical company benefited at the beginning of the year.
Abundant developments in the coronavirus pandemic. Besides
a good deal came again with the successful drug
Dupixent.

To mean it jumped 14.1 percent in numbers.
The Dutch lighting company had when it presented its
Quarterly figures lower their forecasts and the dividend proposal.
retired, but quarterly operating profit was better
It turned out as expected. In addition, the US bank JPMorgan canceled theirs.
Sales recommendation.

Investors also took the report from
Nestlé food company in. The Swiss had
Hamster buys as a result of the viral crisis in the first quarter
Amazing increase in sales. The action put in the SMI
1.8 percent higher / higher / higher

 ISIN  GB0001383545  FR0003500008  EU0009658145

AXC0354 2020-04-24 / 18:37

Copyright dpa-AFX Wirtschaftsnachrichten GmbH. All rights reserved Redistribution, republication or permanent storage is prohibited without the prior express consent of dpa-AFX.